42023-269-05 : NDC 2026 Code

42023-269-05 : Neostigmine Methylsulfate And Glycopyrrolate ( Prevduo )

Additionally :

You can get information about “42023-269-05” NDC code in 42023-269-05 in HTML format

HTML | 42023-269-05 in TXT (Plain Text) format

TXT | 42023-269-05 in PDF (Portable Document Format)

PDF | 42023-269-05 in XML format

XML formats.

NDC Code : 42023-269-05 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "42023-269-05",
    "PackageDescription": "5 SYRINGE, PLASTIC in 1 CARTON (42023-269-05)  / 3 mL in 1 SYRINGE, PLASTIC (42023-269-01) ",
    "NDC11Code": "42023-0269-05",
    "ProductNDC": "42023-269",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Prevduo",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Neostigmine Methylsulfate And Glycopyrrolate",
    "DosageFormName": "INJECTION",
    "RouteName": "INTRAVENOUS",
    "StartMarketingDate": "20230515",
    "EndMarketingDate": null,
    "MarketingCategoryName": "NDA",
    "ApplicationNumber": "NDA216903",
    "LabelerName": "Endo USA",
    "SubstanceName": "GLYCOPYRROLATE; NEOSTIGMINE METHYLSULFATE",
    "StrengthNumber": ".2; 1",
    "StrengthUnit": "mg/mL; mg/mL",
    "Pharm_Classes": "Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA], Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2024-11-01",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20230515",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}